[go: up one dir, main page]

TR200003801T2 - On-skin compositions and methods to relieve pain - Google Patents

On-skin compositions and methods to relieve pain

Info

Publication number
TR200003801T2
TR200003801T2 TR2000/03801T TR200003801T TR200003801T2 TR 200003801 T2 TR200003801 T2 TR 200003801T2 TR 2000/03801 T TR2000/03801 T TR 2000/03801T TR 200003801 T TR200003801 T TR 200003801T TR 200003801 T2 TR200003801 T2 TR 200003801T2
Authority
TR
Turkey
Prior art keywords
methods
relieve pain
skin compositions
compositions
invention describes
Prior art date
Application number
TR2000/03801T
Other languages
Turkish (tr)
Inventor
W. Murdock Robert
Donald Williams C.
Original Assignee
Pharmaceuticals Applications Asociates, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/106,684 external-priority patent/US6290986B1/en
Application filed by Pharmaceuticals Applications Asociates, Llc filed Critical Pharmaceuticals Applications Asociates, Llc
Publication of TR200003801T2 publication Critical patent/TR200003801T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut bulus, transdermal uygulama için olan yöntemleri ve bilesikleri anlatir. Bir uygulamada bulus, bifazik çözünürlüge sahip ve/veya bifazik çözünürlüge sahip olan bilesim içeren aminin etkinligini artiran bir amin bilesimin, örnegin kas gevsetici, agrinin hafifletilmesi için transdermal uygulamasi için olan yöntemleri ve bilesikleri anlatir.The present invention describes methods and compounds for transdermal administration. In one embodiment, the invention describes methods and compositions for the administration of an amine composition that enhances the activity of the amine containing biphasic solubility and / or biphasic solubility, for example muscle relaxant, pain relief.

TR2000/03801T 1998-06-29 1999-06-29 On-skin compositions and methods to relieve pain TR200003801T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,684 US6290986B1 (en) 1996-10-24 1998-06-29 Method and composition for transdermal administration of pharmacologic agents
US12290399P 1999-03-05 1999-03-05

Publications (1)

Publication Number Publication Date
TR200003801T2 true TR200003801T2 (en) 2001-06-21

Family

ID=26803907

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03801T TR200003801T2 (en) 1998-06-29 1999-06-29 On-skin compositions and methods to relieve pain

Country Status (18)

Country Link
EP (1) EP1093348A4 (en)
JP (1) JP2002519310A (en)
KR (1) KR20010078754A (en)
CN (1) CN1331576A (en)
AU (1) AU4841599A (en)
BG (1) BG105175A (en)
BR (1) BR9912508A (en)
CA (1) CA2335837A1 (en)
HR (1) HRP20000905A2 (en)
HU (1) HUP0102728A3 (en)
ID (1) ID28213A (en)
IL (1) IL140420A0 (en)
MX (1) MXPA00012767A (en)
NO (1) NO20006604L (en)
PL (1) PL345216A1 (en)
SK (1) SK20012000A3 (en)
TR (1) TR200003801T2 (en)
WO (1) WO2000000120A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
JP2001526648A (en) 1997-04-22 2001-12-18 コセンシス・インコーポレイテッド Semicarbazones and thiosemicarbazones substituted with carbocycles and heterocycles, and uses thereof
EP1629843A3 (en) * 1999-07-01 2006-03-15 Pharmacia & Upjohn Company LLC Reboxetine for treating chronic fatigue syndrome
KR20090087135A (en) 1999-07-01 2009-08-14 파마시아 앤드 업존 캄파니 엘엘씨 Highly selective norepinephrine reuptake inhibitors and methods of using the same
CA2325106A1 (en) * 1999-12-06 2001-06-06 Stanley L. Gore Compositions and methods for intranasal delivery of active agents to the brain
IN191512B (en) * 2000-01-21 2003-12-06 Panacea Biotech
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
CZ302448B6 (en) * 2000-07-20 2011-05-25 Lauras As Pharmaceutical composition
DE10042412B4 (en) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transceiver for bus subscriber of bus system of building system engineering, has two wires, where microcontroller is connected with receiver unit over connection on one hand, which is connected to two wires of bus system
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
PT2218448E (en) 2002-12-13 2016-01-26 Durect Corp Oral drug delivery system comprising high viscosity liquid carrier materials
JP2005154368A (en) * 2003-11-27 2005-06-16 Teikoku Seiyaku Co Ltd Analgesic agent for neuropathic pain containing disopyramide
JP4807721B2 (en) * 2004-01-29 2011-11-02 株式会社 メドレックス Anti-inflammatory analgesic topical
EP3103477A1 (en) 2004-09-17 2016-12-14 Durect Corporation Sustained local anesthetic composition containing saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
JP2007308403A (en) * 2006-05-17 2007-11-29 Kenji Yoshida Skin care preparation
KR100880748B1 (en) * 2006-08-29 2009-02-02 정헌택 Composition for preventing vascular restenosis containing dimethoxycurcumin
DK2117521T3 (en) 2006-11-03 2012-09-03 Durect Corp TRANSDERMAL ADMINISTRATION SYSTEMS INCLUDING BUPIVACAIN
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
EP2219622A1 (en) 2007-12-06 2010-08-25 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
KR101237927B1 (en) * 2009-05-07 2013-03-04 (주)문엔제이 Pharmaceutical composition for preventing or treating neuronal damage and neurological disorders
US8491927B2 (en) 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
TW201521769A (en) 2013-03-15 2015-06-16 Durect Corp Compositions with a rheological modifier to reduce dissolution variability
US9446056B2 (en) * 2014-02-11 2016-09-20 Dr. Reddy's Laboratories Ltd. Parenteral compositions of celecoxib
CN109475505A (en) 2016-07-06 2019-03-15 度瑞公司 Oral dosage form with pharmaceutical composition, barrier layer and drug layer
AU2019365255B2 (en) 2018-10-26 2025-06-12 Viramal Limited Mucoadhesive gel composition
ES2948955T3 (en) 2018-11-30 2023-09-22 Viramal Ltd A method of preparing a gelling agent, the gelling agent thus obtained and the use of said gelling agent
JP2023515918A (en) 2020-01-13 2023-04-17 デュレクト コーポレーション Sustained release drug delivery system with reduced impurities and related methods
FR3108841B1 (en) * 2020-04-06 2023-11-03 Algotherapeutix TOPICAL PHARMACEUTICAL COMPOSITION IN AQUEOUS GEL FORM COMPRISING AT LEAST AMITRIPTYLINE
JP2024503402A (en) 2021-01-12 2024-01-25 デュレクト コーポレーション Sustained release drug delivery systems and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395420A (en) * 1981-12-09 1983-07-26 Bernstein Joel E Method and composition for treating pruritis
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain

Also Published As

Publication number Publication date
NO20006604D0 (en) 2000-12-22
PL345216A1 (en) 2001-12-03
AU4841599A (en) 2000-01-17
KR20010078754A (en) 2001-08-21
EP1093348A4 (en) 2003-07-16
MXPA00012767A (en) 2002-08-09
HUP0102728A3 (en) 2002-12-28
NO20006604L (en) 2001-02-28
EP1093348A1 (en) 2001-04-25
BR9912508A (en) 2001-05-02
WO2000000120A1 (en) 2000-01-06
CA2335837A1 (en) 2000-01-06
HUP0102728A2 (en) 2002-03-28
HRP20000905A2 (en) 2001-08-31
WO2000000120A9 (en) 2000-03-30
ID28213A (en) 2001-05-10
JP2002519310A (en) 2002-07-02
CN1331576A (en) 2002-01-16
SK20012000A3 (en) 2001-08-06
IL140420A0 (en) 2002-02-10
BG105175A (en) 2001-11-30

Similar Documents

Publication Publication Date Title
TR200003801T2 (en) On-skin compositions and methods to relieve pain
TR200103186T2 (en) Quinoline derivatives as inhibitors of MEK enzymes
WO2002053187A3 (en) Methods and transdermal compositions for pain relief
YU49101A (en) Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ES2189235T3 (en) 6-REPLACED PHENYLPHENANTRIDINS.
DK1071474T3 (en) Substituted porphyrins
BG101446A (en) ANTIINEOPLASTIC Cocoa EXTRACTS, METHOD FOR RECEIVING AND USE
TR200302242T2 (en) Pyrolopyrimidines as protein kinase inhibitors
FI972086A7 (en) Novel amino acid derivatives with improved multidrug resistance activity
MXPA05003501A (en) Methods for treating pain by administering a nerve growth factor antagonist and an opioid analgesic and compositions containing the same.
DE60137966D1 (en) ANILINOPYRIMIDINE DERIVATIVES AS "JNK PATHWAY INHIBITORS", COMPOSITIONS AND ASSOCIATED TREATMENT METHODS
TR200100918T2 (en) Inhibition of RAF kinase using aryl and heteroaryl substituted ureas
MY143466A (en) Inhibitors of tyrosine kinases
AR024138A1 (en) INHIBITORS OF THE CELL PROLIFERATION
EA200401284A1 (en) SUBSTITUTED BENZEZOLES AND THEIR APPLICATION AS RAF KINASE INHIBITORS AS AN INHIBITORS
TR199902194T2 (en) Substituted nitrogen-containing heterocycles as +p38 protein kinase inhibitors.
TR200200205T2 (en) Treating chronic pain using MEK inhibitors
TR200102499T2 (en) As a combination therapy in the treatment of neoplasia, a cyclooxygenase-2 inhibitor and a method of using one or more antineoplastic agents
TR200002480T2 (en) Guanidine derivatives for the treatment of izazemi
TR200200204T2 (en) Treating chronic pain using MEK inhibitors.
EA200601118A1 (en) TREATMENT COMBINATIONS
TR200200066T2 (en) Selective iGluR5 receptor antagonists for the treatment of migraine
EP1392328A4 (en) ANTICANCER THERAPY
DK0889886T5 (en) Novel, 6-position substituted phenanthridines
ATE412646T1 (en) THERAPEUTIC AGENTS SUITABLE FOR THE TREATMENT OF PAIN